What companies are GERM's competitors?

ETFMG Treatments, Testing and Advancements ETF (GERM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GERM compare to its peers?

The peer comparison table on this page shows ETFMG Treatments, Testing and Advancements ETF (GERM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GERM operate in?

ETFMG Treatments, Testing and Advancements ETF (GERM) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GERM (ETFMG Treatments, Testing and Advancements ETF) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

GERM

ETFMG Treatments, Testing and Advancements ETF

AMEX·Asset Management · Financial Services

$19.16$0.06−0.29%

Market cap$9.59M·Market closed·Sep 5 7:53 PM UTC

Frequently Asked Questions About GERM

What companies are GERM's competitors?: ETFMG Treatments, Testing and Advancements ETF (GERM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GERM compare to its peers?: The peer comparison table on this page shows ETFMG Treatments, Testing and Advancements ETF (GERM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GERM operate in?: ETFMG Treatments, Testing and Advancements ETF (GERM) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GERM (ETFMG Treatments, Testing and Advancements ETF) is no longer actively trading.

GERM

ETFMG Treatments, Testing and Advancements ETF

AMEX·Asset Management · Financial Services

$19.16$0.06−0.29%

Market cap$9.59M·Market closed·Sep 5 7:53 PM UTC

Peers


CUBS	Asian Growth Cubs ETF	$18.85	$10.4M
KALL	KraneShares MSCI All China Index ETF	$22.28	$9.9M
HEET	Hartford Schroders ESG US Equity ETF	$24.59	$9.9M
PLAT	WisdomTree Growth Leaders Fund	$30.49	$9.9M
BAD	B.A.D. ETF	$11.91	$9.5M
INDF	Nifty India Financials ETF	$31.25	$9.5M
CHIK	Global X MSCI China Information Technology ETF	$13.20	$9.4M
HCOM	Hartford Schroders Commodity Strategy ETF	$14.55	$9.2M
ERSX	ERShares NextGen Entrepreneurs ETF	$11.27	$9.0M
EEMD	AAM S&P Emerging Markets High Dividend Value ETF	$20.09	$8.5M

Frequently Asked Questions About GERM

What companies are GERM's competitors?: ETFMG Treatments, Testing and Advancements ETF (GERM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GERM compare to its peers?: The peer comparison table on this page shows ETFMG Treatments, Testing and Advancements ETF (GERM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GERM operate in?: ETFMG Treatments, Testing and Advancements ETF (GERM) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.